ASCO-HOPA Drug Shortages Survey As part of its continuing effort to monitor and assess the impact of oncology drug shortages in the United States, ASCO is conducting a survey of U.S.-based members in collaboration with the Hematology/Oncology Pharmacy Association (HOPA). The results of previous surveys indicated that ASCO members are encountering serious problems in the accessibility of life-extending oncology drugs. The following questionnaire is intended to help ASCO and HOPA understand the extent of the ongoing problem and examine the impact of legislative and administrative efforts to mitigate drug shortages. This survey should take approximately 10 minutes to complete and is completely anonymous, unless you choose to provide contact information. Question Title * 1. Since July 2012 (when statutory changes to address the changes went into effect), have you noticed any difference in the magnitude of drug shortages? Better A little better Same A little worse Worse Better A little better Same A little worse Worse Question Title * 2. How do you usually learn that a drug is in shortage? (Check all that apply). Distributor (at the time of ordering) Distributor (via unsolicited communication) Colleague Pharmacy Professional Society (e.g., ASCO, HOPA, ASHP, etc.) State-level Society (e.g., ASCO State Affiliate) FDA Other (please describe) Question Title * 3. In the last 6 months, please list any drugs for which you have experienced a shortage. Question Title * 4. In your practice/institution/health system or community, are you aware of drug substitutions due to short supply (replacing one drug for another, including substituting an oral for an IV drug)? For example, levoleucovorin for leucovorin, captecitabine in colorectal cancer. (Check all that apply). Yes, but the substitution was only temporary Yes, and the substitution lasted for more than 6 months No If yes, please explain. Question Title * 5. In your practice/institution/health system or community, are you aware of any of the following responses to drug shortages? (Check all that apply). Altering the doses of certain drugs to extend the drugs' availability Recommending a different treatment regimen due to drug shortages Personal reimportation Contracting with another distributor Inquiring directly with the manufacturer Contacting/sharing with other providers in the region Referring any of your patients elsewhere for treatment Other (please explain) Question Title * 6. Please estimate how many person-hours per week are spent on dealing with oncology-related shortages in your practice/institution/health system by type of professional. Physician Pharmacist Nurse Practitioner/Doctor of Nursing Practice, Physician Assistant, or Nurse Office Manager/Administrator Other Question Title * 7. Does your practice/institution/health system or community have a formal or informal policy for allocating drugs during a shortage? Yes No Question Title * 8. Do you have access to a consultation with an ethics committee if you need it to assist with an allocation decision? Yes No Question Title * 9. If quality information related to specific manufacturers (not individual drugs or lots) such as FDA warning history or FDA information on production reliability, were public and easily accessible, would it influence your purchasing decisions and would you be willing to pay more to purchase supply from a more highly rated manufacturer? Yes, and I would pay more Yes, but I would not pay more No Other (please explain) Question Title * 10. Has the drug distributor(s) you work through been involved in mitigating shortages? Yes, and the distributor(s) has helped to preemptively avert shortages or lessen their impact Yes, but the distributor has NOT helped preemptively avert shortages No, the distributor has NOT been involved in mitigating shortages I do not work with a drug distributor/I am not aware of the distributor’s role in mitigating shortages Other (please explain) Question Title * 11. Please tell us what type of provider you are: Physician Pharmacist Nurse Practitioner/Doctor of Nursing Practice Physician Assistant Nurse Social Worker Other (please specify) Question Title * 12. Please tell us about your primary professional setting: Hospital (inpatient or outpatient) Private Practice (not owned by a hospital or health system) Practice (owned by a hospital or health system) Independent Pharmacy (not part of a hospital or health system or a national chain) National Chain Pharmacy Health Plan or Pharmacy Benefit Manager Pharma/Biotech/Device Company Other (please specify) Question Title * 13. ASCO is developing new ways to communicate about drug shortages. If you would like more information, please leave your name and email address below. Name Email Submit